189 related articles for article (PubMed ID: 11959570)
1. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin.
Vazifeh D; Abdelghaffar H; Labro MT
Antimicrob Agents Chemother; 2002 May; 46(5):1364-74. PubMed ID: 11959570
[TBL] [Abstract][Full Text] [Related]
2. Interaction of macrolides and ketolides with the phagocytic cell line PLB-985.
Abdelghaffar H; Soukri A; Babin-Chevaye C; Labro MT
J Chemother; 2003 Aug; 15(4):350-6. PubMed ID: 12962363
[TBL] [Abstract][Full Text] [Related]
3. Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils.
Vazifeh D; Bryskier A; Labro MT
Antimicrob Agents Chemother; 2000 Mar; 44(3):511-21. PubMed ID: 10681311
[TBL] [Abstract][Full Text] [Related]
4. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin.
Labro MT; el Benna J; Abdelghaffar H
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():51-64. PubMed ID: 8478312
[TBL] [Abstract][Full Text] [Related]
6. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
Pascual A; López-López G; Aragón J; Perea EJ
Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
[TBL] [Abstract][Full Text] [Related]
7. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin.
Vazifeh D; Abdelghaffar H; Labro MT
Antimicrob Agents Chemother; 1997 Oct; 41(10):2099-107. PubMed ID: 9333032
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils.
Labro MT; el Benna J; Babin-Chevaye C
J Antimicrob Chemother; 1989 Oct; 24(4):561-72. PubMed ID: 2559072
[TBL] [Abstract][Full Text] [Related]
9. [Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo].
Labro MT; Bryskier A; Babin-Chevaye C; Hakim J
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):711-4. PubMed ID: 2847106
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
Malathum K; Coque TM; Singh KV; Murray BE
Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro.
Labro MT; Abdelghaffar H; Babin-Chevaye C
Antimicrob Agents Chemother; 2004 Apr; 48(4):1096-104. PubMed ID: 15047507
[TBL] [Abstract][Full Text] [Related]
12. Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
Paulsen P; Simon C; Peters O; Hedderich J; Heim P
Chemotherapy; 1992; 38(3):185-90. PubMed ID: 1324831
[TBL] [Abstract][Full Text] [Related]
13. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.
Vazifeh D; Preira A; Bryskier A; Labro MT
Antimicrob Agents Chemother; 1998 Aug; 42(8):1944-51. PubMed ID: 9687388
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae.
Engler KH; Warner M; George RC
J Antimicrob Chemother; 2001 Jan; 47(1):27-31. PubMed ID: 11152428
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Hoppe JE; Bryskier A
Antimicrob Agents Chemother; 1998 Apr; 42(4):965-6. PubMed ID: 9559823
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
Roblin PM; Hammerschlag MR
Antimicrob Agents Chemother; 1998 Jun; 42(6):1515-6. PubMed ID: 9624507
[TBL] [Abstract][Full Text] [Related]
17. Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model.
Pachot JI; Botham RP; Haegele KD; Hwang K
J Pharm Pharm Sci; 2003; 6(1):1-12. PubMed ID: 12753725
[TBL] [Abstract][Full Text] [Related]
18. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Sep; 41(9):2019-22. PubMed ID: 9303406
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
Shortridge VD; Zhong P; Cao Z; Beyer JM; Almer LS; Ramer NC; Doktor SZ; Flamm RK
Antimicrob Agents Chemother; 2002 Mar; 46(3):783-6. PubMed ID: 11850262
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
J Antimicrob Chemother; 2000 Nov; 46(5):797-802. PubMed ID: 11062201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
